Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease

Chi-Ting Su1, Yen-Wen Liu, Jou-Wei Lin

  • 1Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Insights

Diastolic dysfunction in hemodialysis patients is linked to increased left ventricular filling pressures and cardiac fibrosis. Procollagen type I C-terminal peptide (PICP) may indicate diastolic dysfunction and elevated pressures.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomedical Engineering

Background:

  • Cardiac dysfunction is prevalent in end-stage renal disease (ESRD) patients.
  • Diastolic dysfunction is a common cardiac issue in ESRD patients undergoing hemodialysis.

Purpose of the Study:

  • To investigate the factors determining diastolic dysfunction in ESRD patients on maintenance hemodialysis.
  • To explore the relationship between cardiac fibrosis markers and diastolic dysfunction severity.

Main Methods:

  • Doppler tissue imaging and 2D speckle-tracking echocardiography were used for strain analysis in asymptomatic ESRD patients.
  • Blood markers including albumin, cardiac troponin T, and procollagen type I C-terminal peptide (PICP) were analyzed.

Main Results:

  • All patients exhibited left ventricular (LV) diastolic dysfunction, with 87% having grade 1.
  • Patients with an average E/e' ratio ≥ 13 had elevated PICP levels.
  • PICP correlated significantly with cardiac troponin T, E/e' ratio, and systolic circumferential strain rate.

Conclusions:

  • High average E/e' ratios in hemodialysis patients indicate increased LV filling pressure and cardiac fibrosis severity, preceding systolic dysfunction.
  • PICP shows potential as an indicator for diastolic dysfunction and elevated LV filling pressure in this population.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...